Dr. Ranjana has over three decades of rich global experience in various reputed large pharmaceutical organisations in creating, building and sustaining a collaborative environment and a strong culture of quality and regulatory compliance.
Dr. Ranjana’s most recent role was with Cipla Limited, Mumbai as President & Global Head Quality, Medical Affairs and Pharmacovigilance. She supported all formulations, API, Biotech, R&D facilities around the globe. She led Quality Transformation initiatives with speed, agility and resilience which have yielded significant outcomes. Successfully led and implemented several digital and automation initiatives involving manufacturing and laboratory operations and quality systems.
Prior to this, Dr. Ranjana was with Watson / Actavis, NJ. USA; Endo Pharma, Pennsylvania USA, DuPont Merck Pharma New York, Zenith Goldline Pharma New York, NMC Labs / Al Pharma New York and so on.
Dr. Ranjana Pathak has been the recipient of prestigious awards and accolades, some of the recent ones are listed below,
- 2018 – Women of the Year award by UBS Forums
- Zee Business presented National Healthcare Leadership Award 2019 – Woman Leader of the year.
- Featured in the Pharmaceutical Engineering, Jan-Feb 2020 edition – “An advocate for Quality”.
- Article published - Chapter on Building an Organizational Quality Culture in Pharmaceutical Regulatory Inspections 2nd Edition, 2020
Dr. Ranjana completed her MBA in the US, then completed her ‘Doctorate of Health Administration (DHA)’, at University of Phoenix. She also studied Leadership and Strategy in Pharmaceuticals and Biotechnology at Harvard Business School.